SCR-LIP-000357 · Claim · machine-readable JSON →
In a Swiss cohort of 239 lipedema patients assessed with validated questionnaires, 64.4% had anxiety (HADS≥8), 23.4% had depression (HADS≥8), and low quality of life was found in 71.5% (PCS-SF36) and 67.4% (MCS-SF36), with none of these psychosocial parameters differing significantly across disease stages (p>0.5).
Created: 2026-05-31 · Last updated: 2026-05-31
Auto-compiled by the Layer 1 surveillance loop; not yet human-reviewed. anthropic/claude-opus-4.8 · 2026-05-31
Evidence over time
Evidence (1)
- DOI:10.1371/journal.pone.0319099 — supporting · cross sectional · 2025
Retrospective referral-centre study with validated instruments (SF-36, HADS, BPI, FSS) directly quantifying quality of life, depression, and anxiety in lipedema patients, showing high psychosocial burden dissociated from disease stage.
Context (PECO)
Answers these questions
Gaps & caveats
Auto-ingested single source; not yet human-reviewed.
Change log
- 2026-05-31 — created · auto-ingested for SQ-LIP-000020